Loading...
•
Dec 31, 2019
Surmodics Q1 2020 Earnings Report
Surmodics' first quarter of fiscal year 2020 results were announced, with revenue increasing by 2% year-over-year and a partnership with Medtronic being established.
Key Takeaways
Surmodics reported a 2% increase in revenue for the first quarter of fiscal year 2020, reaching $22.6 million. GAAP EPS was $0.01, and non-GAAP EPS was $0.05. A partnership with Medtronic was announced for the distribution of the TelemarkTM coronary support catheter.
Revenue increased by 2% year-over-year, reaching $22.6 million.
GAAP EPS was reported at $0.01.
Non-GAAP EPS was reported at $0.05.
A partnership with Medtronic was announced for the distribution of the TelemarkTM coronary support catheter.
Surmodics
Surmodics
Surmodics Revenue by Segment
Revenue by Segment
Medical Device Revenue
CapyFin.comIn Vitro Diagnostics Revenue
CapyFin.com Forward Guidance
For the fiscal year ending September 30, 2020, Surmodics anticipates revenue in a range of $87 million to $91 million, diluted GAAP EPS in a range of ($0.60) to ($0.30), and non-GAAP diluted EPS in a range of ($0.44) to ($0.14).
Revenue & Expenses
Visualization of income flow from segment revenue to net income